This site is intended for US residents 18 years of age and older

INDICATIONS AND USAGE

SPRYCEL® (dasatinib) is a prescription medicine used to treat:

  • adults with newly diagnosed Philadelphia chromosome–positive (Ph+) chronic myeloid leukemia (CML) in chronic phase
  • adults with Ph+ CML who no longer benefit from, or did not tolerate, other treatment, including imatinib
  • adults with Ph+ acute lymphoblastic leukemia (Ph+ ALL) who no longer benefit from, or did not tolerate, other treatment
  • children 1 year of age and older with Ph+ CML in chronic phase
  • children 1 year of age and older with newly diagnosed Ph+ ALL in combination with chemotherapy

It is not known if SPRYCEL is safe and effective in children under 1 year of age.

SPRYCEL DIGITAL HANDBOOK

It can be overwhelming to find out you have Ph+ CML. It is only natural to feel worried, fearful, and uncertain at this time. Find information that may help you as you learn more about your treatment.

WHY YOUR TREATMENT MILESTONES MATTER

What are “treatment milestones”?

In Ph+ CML, treatment results are called “milestones.” Your doctor uses treatment milestones to see how you're responding to your treatment plan.

HOW SPRYCEL WORKS

In Ph+ CML, an abnormal protein (BCR-ABL1) triggers the overproduction of damaged white blood cells. SPRYCEL® (dasatinib) works by helping to reduce the number of damaged white blood cells in your body.

SPRYCEL CLINICAL STUDY

More patients taking SPRYCEL achieved the study’s treatment milestones than those taking imatinib.

STUDY RESULTS AND SIDE EFFECTS

Below are study results and a list of side effects reported in adults in the SPRYCEL clinical study.

TAKING SPRYCEL

SPRYCEL is taken once daily, with or without food.

If you have Ph+ CML in chronic phase, the usual dose is 100 mg. Your healthcare provider may change your dose or temporarily stop treatment with SPRYCEL.

ADULT SAFETY INFORMATION

Medications like SPRYCEL can cause side effects. Read about them here.

TREATMENT TIPS

Ask your doctor if the tips below are right for you.

SPRYCEL FINANCIAL SUPPORT RESOURCES

Bristol Myers Squibb is committed to helping patients gain access to their prescribed BMS medications.

ADDITIONAL Ph+ CML RESOURCES

Many organizations offer information and resources for those living with CML. See the list of organizations below.

Back
to Top